TrialClinical cancer research : an official journal of the American Association for Cancer Research2011

Phase II study of dasatinib in relapsed or refractory chronic lymphocytic leukemia.

Philip C Amrein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.